VIF anatagonist: lead Inhibitor Identification

  • Stevenson, Mario (PI)
  • Mansfield, Keith G. (PI)
  • Rana, Tariq (PI)
  • Sanders-Beer, Brigitte Elisabeth (PI)
  • Beer, Brigitte (PI)

Project: Research project

StatusFinished
Effective start/end date1/1/073/31/15

Funding

  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $1,344,436.00
  • National Institutes of Health: $1,331,690.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $1,089,177.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $1,326,345.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $1,222,320.00

Fingerprint

HIV-1
Antiviral Agents
Cytidine Deaminase
Primate Lentiviruses
Medical Schools
Encephalitis
Virion
Macaca
vif Gene Products
intellectual property
Macrophages
Ranidae
In Vitro Techniques
Virology
Mutation
Organized Financing
Complementary DNA
Drug Discovery
Product Packaging
Infection

ASJC

  • Medicine(all)